Stifel Financial’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $586K | Sell |
17,746
-968
| -5% | -$32K | ﹤0.01% | 2682 |
|
|
2025
Q1 | $752K | Sell |
18,714
-6,329
| -25% | -$254K | ﹤0.01% | 2415 |
|
|
2024
Q4 | $1.18M | Sell |
25,043
-24
| -0.1% | -$1.13K | ﹤0.01% | 2150 |
|
|
2024
Q3 | $1.32M | Buy |
25,067
+1,959
| +8% | +$103K | ﹤0.01% | 2037 |
|
|
2024
Q2 | $1.25M | Sell |
23,108
-7
| -0% | -$379 | ﹤0.01% | 2018 |
|
|
2024
Q1 | $1.62M | Buy |
23,115
+8
| +0% | +$561 | ﹤0.01% | 1878 |
|
|
2023
Q4 | $1.93M | Sell |
23,107
-458
| -2% | -$38.2K | ﹤0.01% | 1693 |
|
|
2023
Q3 | $694K | Sell |
23,565
-2,112
| -8% | -$62.2K | ﹤0.01% | 2297 |
|
|
2023
Q2 | $838K | Buy |
25,677
+46
| +0.2% | +$1.5K | ﹤0.01% | 2191 |
|
|
2023
Q1 | $902K | Buy |
25,631
+522
| +2% | +$18.4K | ﹤0.01% | 2127 |
|
|
2022
Q4 | $1.15M | Sell |
25,109
-2,006
| -7% | -$91.9K | ﹤0.01% | 1894 |
|
|
2022
Q3 | $1.31M | Sell |
27,115
-136
| -0.5% | -$6.59K | ﹤0.01% | 1769 |
|
|
2022
Q2 | $1.07M | Sell |
27,251
-1,066
| -4% | -$41.9K | ﹤0.01% | 1943 |
|
|
2022
Q1 | $1.04M | Sell |
28,317
-152
| -0.5% | -$5.6K | ﹤0.01% | 2083 |
|
|
2021
Q4 | $1.3M | Sell |
28,469
-1,779
| -6% | -$81K | ﹤0.01% | 1929 |
|
|
2021
Q3 | $1.08M | Buy |
30,248
+7,116
| +31% | +$254K | ﹤0.01% | 2035 |
|
|
2021
Q2 | $458K | Buy |
23,132
+11
| +0% | +$218 | ﹤0.01% | 2635 |
|
|
2021
Q1 | $538K | Buy |
23,121
+8,661
| +60% | +$202K | ﹤0.01% | 2438 |
|
|
2020
Q4 | $301K | Buy |
14,460
+2,433
| +20% | +$50.6K | ﹤0.01% | 2593 |
|
|
2020
Q3 | $260K | Sell |
12,027
-739
| -6% | -$16K | ﹤0.01% | 2484 |
|
|
2020
Q2 | $301K | Buy |
+12,766
| New | +$301K | ﹤0.01% | 2363 |
|